GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.
Related Posts
GlycoMantra received Investor Initiative Award from the NCI (NIH).
July 2017 GlycoMantra received Investor Initiative Award from the NCI (NIH). Through this mechanism,…
GlycoMantra received NIH grant
May 2016 GlycoMantra received NIH grant GlycoMantra received I-Corps grant from the NIH. The I-Corps…